Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Developing the next-generation, AI-enabled commercial space station
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Forte Biosciences is a biotechnology company that focuses on dermatology.
IntelyCare is revolutionizing healthcare staffing, scheduling, and training by offering an enterprise workforce management platform.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Calyxo is a medical device company that improves kidney stone treatment through specialized urology technologies.
AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.
Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
Janus Henderson Investors has invested in 227 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Akero Therapeutics received $366.9M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $31.3B.
Janus Henderson Investors's average investment size is $160.4M across its portfolio of 227 companies.
Recent Janus Henderson Investors portfolio additions include Ocugen, Windward Bio, CARGO Therapeutics, Chinook Therapeutics, P3 Health Partners. These companies were founded in 2020 or later.